ABSTRACT 3Ј-Deoxy-3Ј-fluorothymidine (FLT) is a positron emission tomography (PET) tracer used to identify proliferating tumor cells. The purpose of this study was to characterize FLT transport by human nucleoside transporters (hNTs) and to determine the role of hNTs for FLT uptake in various human cancer cell lines.
Positron emission tomography (PET) is a useful imaging modality that allows visualization and quantification of molecular markers or processes in tissues. The thymidine analog 3Ј-deoxy-3Ј-fluorothymidine (FLT) is considered an indirect proliferation-indicating PET imaging agent because, although it is not incorporated into DNA, its intracellular accumulation correlates well with proliferating cells (Toyohara et al., 2002) . Increased FLT accumulation in proliferating cells is believed to be due to a proliferation-dependent increase in thymidine kinase 1 (TK1) activity, leading to increased intracellular phosphorylation and "trapping" of FLT (Rasey et al., 2002; Grierson et al., 2004; Barthel et al., 2005) . However, FLT must cross plasma membranes before it can interact with TK1, and human nucleoside transporters (hNTs) are thought to be involved in this process because FLT uptake in HL-60 cells was significantly reduced by inhibiting human equilibrative nucleoside transporter 1 (hENT1) (Kong et al., 1992) .
hNTs are involved in the cellular uptake of physiological nucleosides, nucleoside analogs, and, in some instances, nucleobases (Kong et al., 2004) . Extracellular adenosine concentrations, which affect various cardiovascular and neurological processes, are influenced by hNTs (Shryock and Belardinelli, 1997; Latini and Pedata, 2001) . Many clinical antineoplastic and antiviral nucleoside analogs gain intracellular access by hNT-mediated transport across plasma membranes (Mackey et al., 1998; Pastor-Anglada et al., 1998) .
There are two different families of hNTs: the hENTs (also known as the SLC29 family) and the concentrative nucleoside transporters (hCNTs, also known as the SLC28 family). hENTs mediate bidirectional transport of nucleosides across biological membranes and are found in most tissues in the body. The four hENT family members are hENT1, -2, -3, and -4 (Griffiths et al., 1997a,b; Baldwin et al., 2005; Barnes et al., 2006) . hENT1 seems to be ubiquitously distributed in cells and tissues and has broad permeant selectivity, transporting a structurally diverse array of natural and synthetic nucleosides. NBMPR selectively inhibits hENT1 at nanomolar concentrations and has been used to functionally distinguish hENT1 from other hNTs (Griffiths et al., 1997a) . hENT2 is also broadly selective, transporting natural and some synthetic nucleosides as well as some nucleobases. hENT3 is a pH-dependent low-affinity transporter of broad nucleoside selectivity with a N-terminal dileucine motif that targets the transporter toward intracellular membranes that colocalize with lysosomal markers . hENT4, found predominantly in the heart and brain, displays pH-dependent adenosine-selective transport (Barnes et al., 2006) . hCNTs couple the transport of nucleosides and sodium or, in the case of hCNT3, protons down their electrochemical gradients to concentrate nucleosides within cells. The three hCNT family members are hCNT1, -2, and -3 (Ritzel et al., 1997 (Ritzel et al., , 2001 Wang et al., 1997) . hCNT1 is pyrimidine nucleoside-selective, transporting uridine, cytidine, and thymidine most efficiently (Ritzel et al., 1997) . hCNT2 is purine nucleoside-selective and efficiently transports adenosine, guanosine, and inosine, although it also transports uridine (Wang et al., 1997) . hCNT3 is broadly selective, transporting both purine and pyrimidine nucleosides with high affinities (Ritzel et al., 2001 ). The Na ϩ -nucleoside coupling ratio for hCNT1 and hCNT2 is 1:1 whereas hCNT3 has a Na ϩ -nucleoside ratio of 2:1 and H ϩ -nucleoside ratio of 1:1 .
Although the permeant selectivities of hNTs have been extensively characterized for many nucleoside analogs, relatively little is known about how hNTs transport FLT. The main objectives of the current study were to determine how well the hNTs interact with and transport FLT and to determine which hNTs are important for FLT uptake in various human cancer cell lines. Using [ 3 H]FLT to follow cellular uptake, we show that FLT was transported by hENT1, hENT2, hCNT1, and hCNT3 and that hENT1 was responsible for the majority of hNT-mediated [ 3 H]FLT uptake in the cell lines tested. In five of the six cell lines tested, a strong correlation was observed between the abundance of hENT1 at the extracellular surface and FLT uptake. , uridine, FLT, N-methyl-D-glucamine (NMDG) , dilazep, and NBMPR were purchased from Sigma-Aldrich (St. Louis, MO). All other reagents were of analytical grade and were purchased from commercial sources.
Materials and Methods

Materials
Inhibitor-Sensitivity Assays with hNT-Producing Yeast Cells. Inhibitor-sensitivity assays were performed as described previously (Zhang et al., 2003; Vickers et al., 2004) . In brief, yeast cultures producing recombinant hNTs (see (Visser et al., 2002; Zhang et al., 2003 Zhang et al., , 2005 for construction of yeast strains) were maintained in complete minimal medium (CMM) containing 0.67% (w/v) yeast nitrogen base (Difco, Detroit, MI), amino acids (to maintain auxotrophic selection), and 2% (w/v) glucose (CMM/GLU). Yeast cells were washed three times with CMM/GLU, pH 7.4, resuspended to an OD 600 of 4, and added to "preloaded" 96-well plates containing CMM/GLU, pH 7.4, with either FLT or thymidine (at desired concentrations) and [ 3 H]uridine. Nonspecific binding and uptake of [ 3 H]uridine were determined by incubating wells with 10 mM uri- 
Purchased as a kit from Applied Biosystems hCNT2-R 900 Assay ID Hs00188407_m1 hCNT2-P 400 (Sequences not given) AF305210 hCNT3-F 280 (Cheng and Prusoff, 1973) , [hENT1, 43 M; hENT2, 190 M; hCNT1, 9.2 M; hCNT2, 29 M; hCNT3, 8.7 M (Zhang et al., 2003 Vickers et al., 2004) ]. Unless otherwise indicated, all data were analyzed using Prism version 4 software (GraphPad Software Inc., San Diego, CA).
Transport Assays in hNT-Producing Xenopus laevis Oocytes. hNT cDNAs in the X. laevis expression vector pGEM-HE were transcribed with T7 polymerase using the mMESSAGE mMACHINE (Ambion, Austin, TX) transcription system, and produced in oocytes of X. laevis by standard procedures (Yao et al., 2000) . Healthy defolliculated stage VI oocytes were microinjected with 20 nl of water or 20 nl of water containing RNA transcripts (20 ng) and incubated in modified Barth's medium (changed daily) at 18°C for 72 h before the assay of transport activity Transport assays were performed at room temperature (20°C) on groups of 10 to 12 oocytes in 200 l of transport buffer as described previously (King et al., 2006) . Incubations were for 30 min to measure cellular uptake, and 1 min to measure initial rates of transport. Except where otherwise indicated, the concentration of radiolabeled permeant was 20 M. After incubation periods, oocytes were rapidly washed six times in ice-cold transport medium to remove extracellular radioactivity. Oocytes were dissolved in 5% (w/v) SDS and measured for radioactivity by liquid scintillation counting. Presented as picomoles per oocyte per 30 min (cellular uptake) or picomoles per oocyte per min (initial rate of transport), values were corrected for nonmediated uptake measured in control, water-injected oocytes.
Cell Culture. Because of the potential utility of FLT-PET in lung, breast, and brain cancers (Been et al., 2004) , A549, MCF-7, and U251 cells (derived from a lung carcinoma, breast adenocarcinoma, and glioblastoma, respectively) were used in this study. In addition, the pancreatic carcinoma cell lines MIA PaCa-2 and Capan-2 were tested because FLT-PET may have applications in treatment planning of pancreatic cancer, and the renal carcinoma cell line A498 was tested because it is one of the few cell lines known to possess hCNT3, which is capable of transporting FLT, and FLT-PET may be useful for detecting renal tumors (Lawrentschuk et al., 2006) . MCF-7, A549, U251, and A498 cells were maintained in RPMI 1640 medium containing 10% (v/v) fetal bovine serum (FBS). MIA PaCa-2 cells were maintained in Dulbecco's modified Eagle's medium with 4.5 g/l glucose, 1.5 g/l sodium bicarbonate, 10% (v/v) FBS, and 2.5% (v/v) horse serum. Capan-2 cells were maintained in McCoy's 5A medium with 10% (v/v) FBS. For all transport and binding experiments, cells were inoculated in 12-well plates at 5 ϫ 10 4 (MCF-7 and Capan-2), 4 ϫ 10 4 (U251 and A498), 3 ϫ 10 4 (MIA PaCa-2), and 2.5 ϫ 10 4 (A549) cells/well. Cultures reached ϳ50% confluence after plates were in- cubated at 37°C with 5% CO 2 for 72 h at which point cells were used for equilibrium binding or uptake assays.
Quantitative Real-Time RT-PCR. RNA was isolated from cell lines using the RNeasy kit (Qiagen, Mississauga, Ontario) and 2 g of RNA for each reaction was reverse-transcribed into DNA using the TaqMan Gold RT-PCR kit (Applied Biosystems, Foster City, CA) following the manufacturer's instructions. For each real-time PCR reaction, cDNA (0.53 l/well) was added to 2ϫ TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA) that contained primers and probes (see Table 1 ) in a final volume of 20 l/well. Reactions were run in triplicate on 96-well plates using real-time PCR (7900HT Fast Real-Time PCR; Applied Biosystems, Foster City, CA) with standard default settings. Relative quantification of RNA was determined with use of the ⌬⌬C T method (Livak and Schmittgen, 2001) , with glyceraldehyde-3-phosphate dehydrogenase to control for RNA loading differences. Validation assays demonstrated that the genes analyzed in this study were amplified with equal efficiencies (data not shown).
Radiotracer Uptake Assays with Cell Lines. Cells in 12-well plates were washed once (1 ml/well) with either Na ϩ buffer (20 mM Tris, 3 mM K 2 HPO 4 , 5 mM glucose, and 145 mM NaCl) or NMDG buffer (20 mM Tris, 3 mM K 2 HPO 4 , 5 mM glucose, and 155 mM NMDG). Cells were incubated for up to 45 min with 0.5 ml/well Na ϩ or NMDG buffer with or without hNT inhibitors (NBMPR or dilazep) to allow interaction between inhibitors and hNTs. Cells were then incubated with 0.5 ml/well Na ϩ or NMDG buffer containing 147 nM
25 kBq/well (0.25 Ci/well)] for 60 min at 37°C. After incubation, radioactive buffer was removed, and cells were washed once with either Na ϩ or NMDG buffer. Cells were solubilized by the addition of 0.5 ml/well 0.5 M KOH for 45 min, and the resulting KOH solutions were analyzed for radioactivity by liquid scintillation counting. Protein content in the KOH solutions was determined by protein assay (Bio-Rad Laboratories, Hercules, CA).
The role of hENT1 in the uptake of FLT was determined by assessing [
3 H]FLT uptake in graded NBMPR concentrations (0.003-100 nM). Cells in 12-well plates were washed once with Na ϩ buffer and incubated for 60 min at 37°C with 1 ml/well Na to cells in the presence or absence of 1 M NBMPR represented nonspecific and total binding, respectively, and the difference between the two, which represented site-specific binding, was used to determine binding parameters (B max and K d values). Equilibrium binding experiments were also performed using FTH-SAENTA to determine the relative proportions of extracellular and intracellular NBMPR binding sites. FTH-SAENTA, being membrane impermeable, has been shown to interact only with the extracellular NBMPR binding sites (Visser et al., 2007) . Cells in 12-well plates were washed twice and then incubated for 60 min with 1 ml/well Na 
Results
Interaction of FLT with Recombinant hNTs in Yeast
Cells. Zhang et al. (2003 Zhang et al. ( , 2005 developed an assay that assesses the ability of nucleoside analogs to inhibit uridine uptake by yeast producing various recombinant hNTs that provides a measure of the apparent affinities of the hNTs for nucleoside analogs. Graded concentrations of thymidine and FLT were used to inhibit [ 3 H]uridine uptake by 50%) that were converted to K i values. Thymidine K i values for hENT1, hENT2, hCNT1, hCNT2, and hCNT3 were 74 Ϯ 17, 160 Ϯ 10, 20 Ϯ 3, 1200 Ϯ 200, and 31 Ϯ 5 M, respectively. FLT displayed K i values for hENT1, hENT2, hCNT1, hCNT2, and hCNT3 that were 12-, 3.4-, 5.0-, Ͼ8.3-, and 15-fold larger than thymidine K i values, respectively, suggesting that substitution of fluorine for the 3Ј-hydroxyl group significantly decreased the affinities of the hNTs for FLT. hCNT1 displayed the lowest K i value (i.e., Figure 2B . (Fig. 2B) ; the K m and V max values are presented in Table 2 . hENT1 and hENT2 displayed greater transport capacities and lower apparent affinities (larger V max and K m values, respectively) for [ 3 H]FLT than hCNT1 and hCNT3. The V max /K m ratio, a measure of transport efficiency, was approximately 6-fold greater for hCNT1 and hCNT3 than for hENT1 and hENT2, suggesting that hCNT1 and hCNT3 transport [ 3 H]FLT more efficiently than hENT1 and hENT2 at lower (micromolar) concentrations.
Relative Quantification of hNTs in Cell Lines. Because FLT was shown to be a permeant of several recombinant hNTs, it was expected that cellular accumulation of FLT would be influenced by expression of hNT transcripts in the cancer cell lines used in this study. Relative quantification of hNT-transcript levels was determined by real-time PCR (Fig. 3) . All genes analyzed were amplified with equal efficiencies, and glyceraldehyde-3-phosphate dehydrogenase was used as the RNA loading control. Transcript levels of hENT1 were 7-, 11-, 25-, and 340-fold greater than those of hENT2, the second most abundant hNT, in A549, MIA PaCa-2, U251, and A498 cells, respectively, whereas transcript levels of hENT2 were equal to and 3-fold greater than those of hENT1 in MCF-7 and Capan-2 cells, respectively. For all cell lines, hENT1 transcripts were at least 300-fold greater than hCNT1, -2, and -3 transcripts, and hCNT2 was detectable only in A549 cells, suggesting that hCNT1, hCNT2, and hCNT3 play minor roles in cellular uptake of nucleosides in the cell lines tested. (Fig. 4A) . Na ϩ buffer allowed tracer uptake mediated by both hENTs and hCNTs, whereas NMDG buffer, which lacks Na ϩ , allowed tracer uptake mediated by only hENTs. Buffers with 100 M dilazep inhibited both hENT1 and hENT2 transport, whereas buffers with 100 nM NBMPR inhibited only hENT1 transport. NMDG buffer with 200 M dilazep and 10 mM uridine was used to determine nonmediated tracer uptake. Cellular hENT1 Location in Cell Lines. Although hENT1 is considered a plasma membrane transporter, it has been found in nuclear and mitochondrial membranes (Mani et al., 1998; Lai et al., 2004) . To determine the proportion of intracellular and extracellular NBMPR binding sites (i.e., hENT1 on intracellular and plasma membranes, respectively), [
3 H]NBMPR equilibrium binding assays were performed with or without FTH-SAENTA (Fig. 6) . Unlike NBMPR, FTH-SAENTA does not permeate membranes and can only bind hENT1 on the extracellular surface of the plasma membrane, thereby allowing quantification of extracellular and intracellular NBMPR binding sites (Table 3) . MCF-7 cells had the greatest percentage of NBMPR binding sites on extracellular surfaces, followed by A549, MIA PaCa-2, U251, A498, and Capan-2 cells. MIA PaCa-2 displayed the greatest number of extracellular NBMPR binding sites (4.4 ϫ 10 5 Ϯ 7 ϫ 10 4 sites/cell), which was 2.3-, 3.4-, 4.5-, 7.2-, and 220-fold greater than the extracellular NBMPR binding sites for MCF-7, A549, U251, A498, and Capan-2 cells, respectively.
Relationship between FLT Uptake and Extracellular NBMPR Binding Sites. There was a strong correlation between FLT uptake and extracellular NBMPR binding sites/cell in five of the six cell lines used in this study (P ϭ 0.0011, r 2 ϭ 0.98, Fig. 7 ). MIA PaCa-2, which was excluded from Fig. 7 , had at least a 2-fold greater number of extracellular NBMPR binding sites than any other cell line in this study but had FLT uptake similar to that of U251. For all cells lines except MIA PaCa-2, there was a clear relationship between the levels of extracellular plasma membrane hENT1 and FLT uptake.
Discussion
FLT-PET has been demonstrated to be useful for determining the proliferative status of various tumor types (Been et al., 2004) . Although FLT metabolism is generally considered the rate-limiting step for cellular FLT accumulation, some studies have suggested the importance of FLT transport for FLT accumulation. RIF-1 xenograft tumors in mice displayed a 1.8-fold increase in [
18 F]FLT uptake when tumor-bearing mice were given an intraperitoneal dose of 5-fluorouracil (Perumal et al., 2006) . Although RIF-1 tumors displayed no change in TK1 protein or ATP levels, NBMPR binding to cultured RIF-1 cells increased 50% after a 2-h incubation with 10 g/ml 5-fluorouracil, suggesting that FLT transport was the rate-limiting process for FLT accumulation in RIF-1 tumors. However, the increased tumor uptake of [ 18 F]FLT may have been caused by depletion of cellular TMP pools as a result of inhibition of thymidylate synthase, which produces TMP from dUMP. Decreased TMP pools allow greater phosphorylation of FLT-monophosphate to FLT-diphosphate by thymidylate kinase, which is the rate-limiting enzyme involved in FLT metabolism (Grierson et al., 2004) .
The current study examined interactions between hNTs and FLT and determined which hNTs were capable of mediating FLT transport. Substitution of the 3Ј-hydroxyl group of thymidine with a fluoro group increased K i values for inhibition of uridine transport (a measure of interaction with hNTs) by 3-to 15-fold. This reduction in hNTs' apparent affinities for FLT was relatively small considering the importance of the 3Ј-hydroxyl group in uridine for nucleoside-hNT interaction-i.e., using the yeast inhibitor-sensitivity assay described herein, hCNT3, hENT1, hCNT2, and hCNT1 displayed 39-, Ͼ54-, Ͼ107-, and 135-fold larger K i values, respectively, for 3Ј-deoxyuridine than for uridine (Zhang et al., 2003; Vickers et al., 2004) . FLT interacted poorly with hCNT2, and this explains the low amount of FLT uptake observed in oocytes producing hCNT2. For all cell lines except MIA PaCa-2, a strong correlation was observed between extracellular NBMPR binding sites and [
3 H]FLT uptake. MIA PaCa-2 displayed more than 2-fold larger number of extracellular NBMPR binding sites than the other cell lines but did not display proportionally greater FLT uptake, suggesting that FLT phosphorylation was the rate-limiting step for FLT uptake in MIA PaCa-2. When analyzing TK1 mRNA levels using real-time PCR for MIA PaCa-2, Capan-2, and MCF-7, TK1 mRNA levels in MIA PaCa-2 were 26 and 17% of those found in Capan-2 and MCF-7, respectively (data not shown), suggesting that MIA PaCa-2 had low levels of TK1.
Understanding membrane transport of FLT in cells may explain the relatively low sensitivity of FLT-PET compared with the commonly used fluorodeoxyglucose (FDG)-PET. Immunohistochemical staining of hENT1 in 33 frozen sections of primary breast cancers revealed significant variations in hENT1 staining between tumors. Using a 0 -4ϩ intensity staining scale, 4, 5, 7, 14, and 3 sections scored 0, 1ϩ, 2ϩ, 3ϩ, and 4ϩ, respectively (Mackey et al., 2002) . No detectable hENT1 staining was observed in 12% of tumors examined, suggesting that FLT-PET may provide false-negative images for these tumors. Data from FLT-PET pilot studies in breast cancer patients suggested that 7 to 20% of tumors are not detectable by FLT-PET (Smyczek-Gargya et al., 2004; Been et al., 2006) . These tumors may have low levels of hENT1, explaining their unobservable nature in FLT-PET.
hNT levels are variable in almost all cancers studied. RNA analysis of four pancreatic cell lines (NP9, NP18, NP29, and NP31) revealed that hENT1, hENT2, hCNT1, hCNT2, and hCNT3 mRNA levels differed significantly between the four cell lines and only hENT1 mRNA was easily detectable for all four cell lines (García-Manteiga et al., 2003) . When hENT1 levels were analyzed in 21 pancreatic adenocarcinomas using immunohistochemistry, 12 samples displayed no detectable hENT1 in 10 to 100% of adenocarcinoma cells, suggesting that hENT1 is not present in all pancreatic adenocarcinomas (Spratlin et al., 2004) . Variability in [
18 F]FLT uptake between tumors may be partly explained by the considerable interindividual variability in tumor hNT levels (Pennycooke et al., 2001) . In a comparison of RNA levels for hENT1 using matched tumor/normal tissue individual arrays, there was no consistent difference in hENT1 expression levels for kidney, breast, uterus, ovary, colon, lung, stomach, and rectum (Pennycooke et al., 2001) . Only prostate tumors consistently demonstrated decreased hENT1 expression compared with normal tissues (hENT1 tumor levels 47% of normal tissues). These same prostate arrays also exhibited consistently higher levels of hENT2 tumor expression (hENT2 tumor levels 323% of normal tissues), suggesting that prostate tumors still retain the capacity for FLT transport despite the decrease in hENT1 levels. hCNT1 was not detectable in the majority of the matched tissue arrays (breast, prostate, cervix, colon, stomach, and rectum) and consistently displayed low levels of tumor expression in almost all other tested tissues (kidney, uterus, lung, and small intestine), suggesting that neoplastic transformation of these tissues may decrease capacity for FLT transport.
It is interesting to note that cellular hENT1 levels correlated with FLT uptake (present study) and the therapeutic activity of gemcitabine in pancreatic adenocarcinomas (Spratlin et al., 2004) . Patients with pancreatic adenocarcinoma tumors in which more than 90% of tumor cells displayed hENT1 staining had significantly longer median survival times after gemcitabine monotherapy than patients with tumors in which 0 to 90% of tumor cells displayed hENT1 staining. If hENT1 levels influence both FLT uptake and gemcitabine cytotoxicity in pancreatic cancers, perhaps FLT-PET would be useful to determine gemcitabine resistance in pancreatic cancers before gemcitabine treatment. Further studies are required to validate this hypothesis.
Before this study, only hENT1 was known to transport FLT across plasma membranes, and whether the other hNTs could transport FLT was unknown (Kong et al., 1992) . The current study has determined that FLT can interact with and is transported by hENT1, hENT2, hCNT1, and hCNT3. Because of the greater relative abundance of hENT1 in the tested cell lines, [ 3 H]FLT uptake was primarily mediated by hENT1. Small alterations of hENT1 transport activity by treatment with NBMPR reduced [ 3 H]FLT uptake in MCF-7, A549, and Capan-2 cells. A strong correlation was observed between [
3 H]FLT uptake and the number of extracellular NBMPR binding sites/cell for five of the six cell lines tested, demonstrating the importance of hENT1 for FLT uptake.
